A quote from this week's Bulletin "At 9c last week, Viralytics shares carry a market capitalisation of $22m, making it a minnow in the international oncology market estimated to be worth $US34.6bn ($39bn) last year and growing at 20% a year. As Viralytics executive director Dr Phillip Altman pointed out, some 20 million people in Europe, Japan and the US live with cancer. Sales of many cancer products exceed $US1bn."
It is now in the real world with human trials underway and positions are being taken because any whiff of success in those trials and we are looking at a company worth so so so so much more than $22m.....which is pocket money for the international drug companies (CEO's pay packet probably) Don't sell One Fat Lady plus the share issue is underway for you @.08c ....Cheers
VLA Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
